Stifel Financial Corp increased its holdings in Clorox Company (The) (NYSE:CLX) by 4.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 73,956 shares of the company’s stock after acquiring an additional 3,109 shares during the period. Stifel Financial Corp owned approximately 0.06% of Clorox Company (The) worth $9,881,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of CLX. Synovus Financial Corp increased its stake in Clorox Company (The) by 14.5% during the second quarter. Synovus Financial Corp now owns 8,786 shares of the company’s stock worth $1,173,000 after acquiring an additional 1,114 shares during the last quarter. OMERS ADMINISTRATION Corp acquired a new position in shares of Clorox Company (The) in the 2nd quarter valued at $2,184,000. Geode Capital Management LLC lifted its stake in shares of Clorox Company (The) by 4.3% in the 1st quarter. Geode Capital Management LLC now owns 1,247,940 shares of the company’s stock valued at $168,019,000 after purchasing an additional 51,563 shares during the last quarter. IMS Capital Management acquired a new position in shares of Clorox Company (The) in the 2nd quarter valued at $168,000. Finally, Great Lakes Advisors LLC lifted its stake in shares of Clorox Company (The) by 3.3% in the 2nd quarter. Great Lakes Advisors LLC now owns 5,970 shares of the company’s stock valued at $795,000 after purchasing an additional 192 shares during the last quarter. Institutional investors own 71.33% of the company’s stock.

Clorox Company (NYSE:CLX) opened at 129.83 on Wednesday. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The stock has a market cap of $16.76 billion, a price-to-earnings ratio of 24.34 and a beta of 0.39. The stock has a 50 day moving average of $135.19 and a 200 day moving average of $134.73.

Clorox Company (The) (NYSE:CLX) last issued its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.04. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business’s quarterly revenue was up 2.9% on a year-over-year basis. During the same period last year, the company posted $1.30 EPS. Equities analysts expect that Clorox Company will post $5.66 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date is Tuesday, October 24th. Clorox Company (The)’s dividend payout ratio (DPR) is presently 63.04%.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Marea Informative and is the property of of Marea Informative. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at http://www.mareainformativa.com/stifel-financial-corp-has-9-88-million-position-in-clorox-company-the-clx-2/115336/.

CLX has been the subject of a number of research analyst reports. BMO Capital Markets reiterated an “outperform” rating on shares of Clorox Company (The) in a report on Tuesday, September 12th. Jefferies Group LLC reissued a “hold” rating and set a $137.00 price objective (up from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Barclays PLC restated an “equal weight” rating and issued a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a report on Friday, August 4th. Royal Bank Of Canada restated a “hold” rating and issued a $115.00 price objective on shares of Clorox Company (The) in a report on Wednesday, August 2nd. Finally, BidaskClub raised shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. Clorox Company (The) has an average rating of “Hold” and an average target price of $127.81.

In other news, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total value of $1,280,798.01. Following the transaction, the senior vice president now directly owns 20,614 shares in the company, valued at approximately $2,862,666.18. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Dawn C. Willoughby sold 2,158 shares of the firm’s stock in a transaction dated Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 21,242 shares of company stock valued at $2,944,449. 1.00% of the stock is owned by company insiders.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.